A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer (BC) subtype and lacks targeted treatment. It is diagnosed by the absence of immunohistochemical expression of several biomarkers, but this method still displays some interlaboratory variability. DNA methylome aberrations are...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendaza, Saioa, Guerrero-Setas, David, Monreal-Santesteban, Iñaki, Ulazia-Garmendia, Ane, Cordoba Iturriagagoitia, Alicia, De la Cruz, Susana, Martín-Sánchez, Esperanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533184/
https://www.ncbi.nlm.nih.gov/pubmed/34680511
http://dx.doi.org/10.3390/biomedicines9101394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533184/
https://www.ncbi.nlm.nih.gov/pubmed/34680511
http://dx.doi.org/10.3390/biomedicines9101394

Ejemplares similares